1899
125 years ago
Company
Founding
We started by selling Ikatsu, a stomach medicine. Then, we expanded into the eye care, skin medicine, and skincare fields.
*as of December 2024
Sales
We contribute to society by developing products based on customer needs.
Consolidated
sales
2708
billion yen
Consolidated
operating profit
40
billion yen
*FY2023
Sales by Product and Service
Skincare products launched since the 2000s account for more than 60% of total sales.
Other
4
%
Eye care
20
%
Oral
medications/
food 11 %
medications/
food 11 %
Skincare
65
%
*FY2023
Sales by region
Our network spans 110 countries, and we are developing our business in each country.
Europe
5
%
Other
1
%
America
7
%
Asia
29
%
Japan
58
%
*FY2023
ROHTO Group partners
In order to establish a well-being society, we engage in business as a unified group.
Consolidated
subsidiaries
47
companies
Partner
companies
41
companies
*FY2023
No. of employees
We engage in a diverse range of businesses with a small but skilled staff.
Main
company
1687
Consolidated 7259
*FY2023
Ratio of men and women
Employees of different generations work together as equals.
Women 982
Men 705
*FY2023
Percentage of female managers
We continue to create an environment where staff can display their skills regardless of gender.
328 %
*FY2023
Manufacturing
Best sellers
We have created a wide range of product groups and many brands that have been popular over the long term.
24 brands
*Brands that have been selling for at least 10 consecutive
years as of FY2023with at least 1 billion yen in sales in FY2023
Research and development costs
We are continuing early-stage investments in ophthalmology and regenerative medicine with the goal of medium-to-long-term growth.
133
billion yen
*FY2022
11
billion yen
*FY2022
Best in category
Our products are at the top of the eye care and skincare categories.
OTC
eye drops
Sales※1
Basic
cosmetics
Sales※2
OTC
eye drops
Sales *1 No,1
Basic cosmetics
Sales *2 No,1
*1 intage SRI+ eye drops category
Estimated sales volume of individual units April 2023 to March 2024
*2. intage SRI+ cosmetics (5 categories)
Estimated sales volume of individual units April 2023 to March 2024
Eye medicine patent portfolio
Our advanced research leads to the development of novel and unique products.
No,1
* Source: Patent Result survey Targeted patents issued between January 1993 and September 9, 2023.
Happy Surprise Voices
A culture of valuing customer opinions for over 70 years. We continue to share opinions with our employees.
2720 times
*FY2023
Findings and suggestions
Each person strives to increase quality while lowering costs.
10587 times
*FY2023
Employees and Workstyles
In-house Double Job
Employees may have concurrent positions across departments in order to uncover new possibilities.
192 employees
*FY2023
External Challenge Work
Employees move away from the company framework and contribute to the world through multiple jobs.
61 employees
*FY2023
Childcare leave usage rate
We aim to promote a work/life balance and create a comfortable work environment.
Women 100 %
Men 464 %
*FY2023
Non-smoking rate
We are making an effort to achieve a 100% non-smoking rate.
978 %
*FY2023
